FDA has approved Skyclarys (omaveloxolone) as the first treatment for Friedreich’s ataxia

 FDA approves first treatment for Friedreich’s ataxia

FDA Widens Path for Rare-Disease Treatments With New Approval

Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS™ (Omavaloxolone), the First and Only Drug Indicated for Patients with Friedreich’s Ataxia

What is SKYCLARYS?

https://s27.q4cdn.com/486207181/files/doc_presentations/2023/20230228_RETA_Deck_SKYCLARYS_Approval_for_Patients_with_Friedreich%E2%80%99s_Ataxia.pdf